The global Cancer Stem Cells (CSCs) market is expected to grow from USD 3.3 billion in 2024 to around USD 8.3 billion by 2034. This growth represents a compound annual growth rate (CAGR) of 9.7% during the forecast period. In 2024, North America led the global market with a 38.6% share, contributing over USD 1.3 billion in revenue. The market is expanding due to the rising burden of cancer,...